Anwen Xiong - Concepedia

Author

Anwen Xiong

Shanghai Pulmonary Hospital

Also Known As

An-Wen Xiong, An-wen Xiong, Anwen Xiong

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Shanghai Pulmonary Hospital Tongji University Hunan Cancer Hospital Henan Cancer Hospital Central South University

About

Anwen Xiong is an author at Shanghai Pulmonary Hospital specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	360
2	Immunology	5	5	161
3	Health Sciences	2	2	56
4	Cell Biology	2	2	34
5	Molecular Medicine	1	1	24

Anwen Xiong

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer Fengying Wu, Jue Fan, Yayi He, Nature Communications	2021	759
MicroRNA-214 Promotes Myogenic Differentiation by Facilitating Exit from Mitosis via Down-regulation of Proto-oncogene N-ras Jun Liu, Xiao-ju Luo, Anwen Xiong, Journal of Biological Chemistry	2010	132
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China Anwen Xiong, Lei Wang, Jianhua Chen, The Lancet MedicineImmunologyPathologyImmune Checkpoint InhibitorCancer Treatment	2025	90
Safety and effectiveness of neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in stage II–III NSCLC (LungMate 002): an open-label, single-arm, phase 2 trial Xinsheng Zhu, Liangdong Sun, Nan Song, BMC Medicine	2022	64
A Phase II Clinical Trial of Apatinib in Pretreated Advanced Non-squamous Non–small-cell Lung Cancer Fengying Wu, Shijia Zhang, Anwen Xiong, Clinical Lung Cancer MedicinePathologyBronchial NeoplasmCancer TreatmentOncology	2018	60
Spatial multi-omics revealed the impact of tumor ecosystem heterogeneity on immunotherapy efficacy in patients with advanced non-small cell lung cancer treated with bispecific antibody Xinyu Song, Anwen Xiong, Fengying Wu, Journal for ImmunoTherapy of Cancer	2023	56
MicroRNA-31 suppresses medulloblastoma cell growth by inhibiting DNA replication through minichromosome maintenance 2 Yucui Jin, Anwen Xiong, Ziyu Zhang, Oncotarget	2014	52
A Phase 1b Study of Ivonescimab, a Programmed Cell Death Protein-1 and Vascular Endothelial Growth Factor Bispecific Antibody, as First- or Second-Line Therapy for Advanced or Metastatic Immunotherapy-Naive NSCLC Lei Wang, Yongzhong Luo, Shengxiang Ren, Journal of Thoracic Oncology	2023	50
Characterization of Liver Metastasis and Its Effect on Targeted Therapy in EGFR-mutant NSCLC: A Multicenter Study Tao Jiang, Ruirui Cheng, Guowei Zhang, Clinical Lung Cancer MedicinePathologyEgfr-mutant NsclcLiver CancerTargeted Therapy	2017	48
Exon 20 YVMA insertion is associated with high incidence of brain metastasis and inferior outcome of chemotherapy in advanced non-small cell lung cancer patients with HER2 kinase domain mutations Shuo Yang, Yan Wang, Chao Zhao, Translational Lung Cancer Research	2021	44

Page 1